KDM4D and liver cancer: Consistently, Western blot results showed that JMJD2D knockdown enhanced the cleavage of PARP (poly ADP-ribose polymerase, C-PARP), a marker of cell apoptosis, in liver cancer cells treated with chemotherapeutic drugs (Figure 3B).